Vanguard Capital Wealth Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,300
| Closed | -$533K | – | 122 |
|
|
2024
Q2 | $533K | Hold |
2,300
| – | – | 0.36% | 59 |
|
|
2024
Q1 | $496K | Hold |
2,300
| – | – | 0.35% | 66 |
|
|
2023
Q4 | $595K | Hold |
2,300
| – | – | 0.48% | 42 |
|
|
2023
Q3 | $591K | Hold |
2,300
| – | – | 0.55% | 44 |
|
|
2023
Q2 | $655K | Hold |
2,300
| – | – | 0.59% | 35 |
|
|
2023
Q1 | $639K | Hold |
2,300
| – | – | 0.64% | 40 |
|
|
2022
Q4 | $637K | Sell |
2,300
-50
| -2% | -$13.8K | 0.74% | 36 |
|
|
2022
Q3 | $627K | Hold |
2,350
| – | – | 0.76% | 34 |
|
|
2022
Q2 | $479K | Hold |
2,350
| – | – | 0.54% | 51 |
|
|
2022
Q1 | $494K | Sell |
2,350
-100
| -4% | -$21K | 0.35% | 72 |
|
|
2021
Q4 | $587K | Buy |
2,450
+100
| +4% | +$24K | 0.42% | 60 |
|
|
2021
Q3 | $665 | Sell |
2,350
-350
| -13% | -$99 | 0.45% | 56 |
|
|
2021
Q2 | $934K | Buy |
2,700
+100
| +4% | +$34.6K | 0.71% | 38 |
|
|
2021
Q1 | $697K | Hold |
2,600
| – | – | 0.59% | 44 |
|
|
2020
Q4 | $633K | Buy |
+2,600
| New | +$633K | 0.58% | 43 |
|
|
2020
Q2 | $682K | Buy |
+2,550
| New | +$682K | 0.8% | 35 |
|
|
2019
Q4 | $712K | Hold |
2,400
| – | – | 0.74% | 34 |
|
|
2019
Q3 | $558K | Hold |
2,400
| – | – | 0.65% | 47 |
|
|
2019
Q2 | $561K | Sell |
2,400
-134
| -5% | -$31.3K | 0.68% | 49 |
|
|
2019
Q1 | $598K | Buy |
2,534
+84
| +3% | +$19.8K | 0.75% | 41 |
|
|
2018
Q4 | $737K | Hold |
2,450
| – | – | 1.1% | 25 |
|
|
2018
Q3 | $865K | Hold |
2,450
| – | – | 0.99% | 25 |
|
|
2018
Q2 | $711K | Hold |
2,450
| – | – | 0.94% | 35 |
|
|
2018
Q1 | $666K | Hold |
2,450
| – | – | 0.88% | 39 |
|
|
2017
Q4 | $780K | Buy |
+2,450
| New | +$780K | 0.98% | 33 |
|